作者: Luni Chen , Goeran Hedenstierna
DOI:
关键词: Cyclooxygenase 、 Nitric oxide 、 Pharmacology 、 Bronchoconstriction 、 Response to treatment 、 Hypoxic pulmonary vasoconstriction 、 Inhalation 、 Chemistry 、 Anesthesia
摘要: Use of inhalable gaseous nitric oxide (NO) in combination with a cyclooxygenase inhibitor for the manufacture medicament treating pulmonary vasoconstriction or airway constriction mammal, including man, order to counteract hypo- non- response treatment donor only and/or rebound case withdrawal said being use therapeutically effective amount accomplish relaxation constriction. A method and pharmaceutical preparation while using above-mentioned combination.